Going forward, we may see more instances in which insurers deny or (temporarily) severely restrict coverage of accelerated ...
Joel Stanley, the founder and former CEO of Charlotte’s Web, is leading an effort to achieve approval from the FDA for a ...
In light of this, the OIG examined the FDA's decision-making process in a sample of 24 accelerated drug approvals. Of the 24 drugs, three approvals deviated from the others -- aducanumab ...
A report from the U.S. FDA's ... process. However, drugmakers whose treatments are granted accelerated approval are required to conduct postmarketing trials to confirm the drug's benefit ...
Our FDA/Food, Drug ... in-process sampling Process monitoring and control decisions that result in minor equipment and process adjustments do not need additional quality unit approval under ...
The FDA approved a pain drug designed to eliminate the risks associated with opioids -- the first new pharmaceutical approach ...